Total Voting Rights
Released : 31 Jul 2023
RNS Number : 5826HChesnara PLC31 July 2023LEI Number: 213800VFRMBRTSZ3SJ06
31st July 2023
CHESNARA plc
("Chesnara" or "the Company")
TOTAL VOTING RIGHTS
In conformity with 5.6.1 of the Disclosure Guidance and Transparency Rules, the Company notifies the market of the following: -
Chesnara's (CSN.L) issued share capital as at the date of this announcement comprised of 150,590,912 ordinary shares of 5p each with no shares held in Treasury. Each share carries one voting right and therefore the total number of voting rights is 150,590,912.
This figure of 150,590,912 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
For further information, please contact:
Investor Enquiries
Sam Perowne
Head of Strategic Development & Investor Relations
Chesnara plc
Media Enquiries
Roddy Watt
Director, Capital Markets
FWD
T - 020 7280 0651 / 07714 770 493
Notes to Editors
Chesnara (CSN.L) is a European life and pensions consolidator listed on the London Stock Exchange. It administers approximately one million policies and operates as Countrywide Assured and CASLP in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.
Following a three-pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios.
Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 18 years in succession.
Further details are available on the Company's website (www.chesnara.co.uk).
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. ENDTVRUWORROKUBUAR